首页 › 基金 › Carlyle Group Inc. › OKUR
Carlyle Group Inc. 对 OKUR 的持仓历史
Onkure Therapeutics Inc · 医疗保健
Carlyle Group Inc. 在 Q3 2026 的 13F 申报中披露持有 OKUR(Onkure Therapeutics Inc)269,895 股,市值约 US$735K,约占其申报组合的 0.01%,在其申报持仓中市值排名第 11 位。 Carlyle Group Inc. 最近 8 个申报季度中有 8 个季度披露了 OKUR 持仓,最早可追溯至 Q4 2024。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
Carlyle Group Inc. 对 OKUR 的持仓演变
Carlyle Group Inc. 于 Q4 2024 首次披露 OKUR 持仓:269,895 股(约 US$2.3M)。 在 8 次申报中,Carlyle Group Inc. 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 269,895 股、市值约 US$735K。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2024 | 269.89K | $2.33M | 新进 |
| Q1 2025 | 269.89K | $1.16M | 持有 |
| Q2 2025 | 269.89K | $642.35K | 持有 |
| Q3 2025 | 269.89K | $742.21K | 持有 |
| Q4 2025 | 269.89K | $771.90K | 持有 |
| Q1 2026 | 269.89K | $1.12M | 持有 |
| Q2 2026 | 269.89K | $1.23M | 持有 |
| Q3 2026 | 269.89K | $735.46K | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 OKUR 与 13F 数据
OKUR(Onkure Therapeutics Inc)属于医疗保健行业。我们追踪的基金中还有 72 只申报持有 OKUR,申报仓位最大的包括:BVF INC/IL (US$14.8M), ACORN CAPITAL ADVISORS, LLC (US$12.9M), StepStone Group LP (US$12.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 OKUR 的基金
- BVF INC/IL 3.24M 股 · $14.76M · Q2 2026
- ACORN CAPITAL ADVISORS, LLC 2.84M 股 · $12.95M · Q2 2026
- StepStone Group LP 2.66M 股 · $12.13M · Q2 2026
- ADAR1 Capital Management, LLC 2.24M 股 · $10.21M · Q2 2026
- Trails Edge Capital Partners, LP 1.44M 股 · $6.56M · Q2 2026
- Vivo Capital, LLC 1.93M 股 · $5.25M · Q3 2026
- Sio Capital Management, LLC 1.08M 股 · $4.92M · Q2 2026
- Prosight Management, LP 978.99K 股 · $4.46M · Q2 2026
- NEA Management Company, LLC 478.55K 股 · $2.18M · Q2 2026
- Sofinnova Investments, Inc. 321.69K 股 · $1.47M · Q2 2026
- Rosalind Advisors, Inc. 150.00K 股 · $684.00K · Q2 2026
- Aisling Capital Management LP 88.61K 股 · $241.45K · Q3 2026
更多关于 Carlyle Group Inc.
常见问题
How long has Carlyle Group Inc. held OKUR?
Carlyle Group Inc. has disclosed OKUR holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is Carlyle Group Inc.'s current position in OKUR?
As of Q3 2026, Carlyle Group Inc. holds 269.89K shares of OKUR (Onkure Therapeutics Inc), valued at $735.46K, representing 0.01% of its reported portfolio and ranking #11.
Has Carlyle Group Inc. been buying or selling OKUR?
In the latest 13F filing (Q3 2026), Carlyle Group Inc. held unchanged its position in OKUR.
Which other funds hold OKUR?
Other major institutional holders of OKUR include BVF INC/IL, ACORN CAPITAL ADVISORS, LLC, StepStone Group LP, among 72 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.